Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer cells with thick glycocalyx barrier evade immune system better: study

2.

Is global cancer care losing its human touch?

3.

Study suggests exercise could reduce breast cancer recurrence

4.

Recently released national data on drug use and abuse among Americans.

5.

PSA Often Unchanged With Enzalutamide Progression


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot